Nakata Y - Search Results

1

Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice.

Yamasaki F, Kanahara N, Nakata Y, Koyoshi S, Yanagisawa Y, Saito T, Oiwa T, Kogure M, Sasaki T, Yoshida T, Kimura H, Iyo M. Yamasaki F, et al. Among authors: nakata y. J Psychopharmacol. 2023 Oct;37(10):992-1002. doi: 10.1177/02698811231177268. Epub 2023 Jul 3. J Psychopharmacol. 2023. PMID: 37395368

2

Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.

Nakata Y, Kanahara N, Kimura H, Watanabe H, Iyo M. Nakata Y, et al. Int Clin Psychopharmacol. 2017 May;32(3):169-173. doi: 10.1097/YIC.0000000000000160. Int Clin Psychopharmacol. 2017. PMID: 28067751

3

Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.

Oda Y, Fujita Y, Oishi K, Nakata Y, Takase M, Niitsu T, Kanahara N, Shirayama Y, Hashimoto K, Iyo M. Oda Y, et al. Among authors: nakata y. Psychopharmacology (Berl). 2017 Oct;234(20):3027-3036. doi: 10.1007/s00213-017-4695-5. Epub 2017 Jul 25. Psychopharmacology (Berl). 2017. PMID: 28744562

4

Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.

Nakata Y, Kanahara N, Iyo M. Nakata Y, et al. J Psychopharmacol. 2017 Dec;31(12):1511-1518. doi: 10.1177/0269881117728428. Epub 2017 Sep 19. J Psychopharmacol. 2017. PMID: 28925317 Review.

5

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.

Oishi K, Kanahara N, Takase M, Oda Y, Nakata Y, Niitsu T, Ishikawa M, Sato Y, Iyo M. Oishi K, et al. Among authors: nakata y. PLoS One. 2018 Nov 8;13(11):e0207133. doi: 10.1371/journal.pone.0207133. eCollection 2018. PLoS One. 2018. PMID: 30408108 Free PMC article.

6

A preliminary exome sequence in three patients with tardive dystonia.

Kanahara N, Nakata Y, Iyo M. Kanahara N, et al. Among authors: nakata y. Psychiatr Genet. 2020 Apr;30(2):57-59. doi: 10.1097/YPG.0000000000000248. Psychiatr Genet. 2020. PMID: 31895084

7

Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis.

Takase M, Kimura H, Kanahara N, Nakata Y, Iyo M. Takase M, et al. Among authors: nakata y. J Psychopharmacol. 2020 May;34(5):540-547. doi: 10.1177/0269881119900982. Epub 2020 Jan 21. J Psychopharmacol. 2020. PMID: 31961236

8

Autistic traits and cognitive profiles of treatment-resistant schizophrenia.

Nakata Y, Kanahara N, Kimura A, Niitsu T, Komatsu H, Oda Y, Ishikawa M, Hasegawa T, Kamata Y, Yamauchi A, Inazumi K, Kimura H, Iyo M. Nakata Y, et al. Schizophr Res Cogn. 2020 Jul 27;22:100186. doi: 10.1016/j.scog.2020.100186. eCollection 2020 Dec. Schizophr Res Cogn. 2020. PMID: 32760657 Free PMC article.

9

Genetic association study detected misalignment in previous whole exome sequence: association study of ZNF806 and SART3 in tardive dystonia.

Kanahara N, Nakata Y, Iyo M. Kanahara N, et al. Among authors: nakata y. Psychiatr Genet. 2021 Feb 1;31(1):29-31. doi: 10.1097/YPG.0000000000000263. Psychiatr Genet. 2021. PMID: 32941384

10

Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR.

Nakata Y, Kanahara N, Kimura A, Niitsu T, Komatsu H, Oda Y, Nakamura M, Ishikawa M, Hasegawa T, Kamata Y, Yamauchi A, Inazumi K, Kimura H, Shiko Y, Kawasaki Y, Iyo M. Nakata Y, et al. J Psychiatr Res. 2021 Jun;138:219-227. doi: 10.1016/j.jpsychires.2021.03.053. Epub 2021 Mar 30. J Psychiatr Res. 2021. PMID: 33866050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,272 results

Search Page